Cargando…

Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites

BACKGROUND: Cytology remains the gold standard for the detection of malignant cells in ascites. However, its sensitivity is limited. The aim of this study was to evaluate DNA methylation biomarkers for the differential diagnosis of benign (ascites in patients without malignancy), malignant (ascites...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Maria, Pützer, Svenja, Gevensleben, Heidrun, Meller, Sebastian, Kristiansen, Glen, Dietrich, Dimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774089/ https://www.ncbi.nlm.nih.gov/pubmed/26937257 http://dx.doi.org/10.1186/s13148-016-0192-7

Ejemplares similares

Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions
por: Dietrich, Dimo, et al.
Publicado: (2013)

Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study
por: Bergheim, Julia, et al.
Publicado: (2018)

SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas
por: Semaan, Alexander, et al.
Publicado: (2016)

Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2017)

CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients
por: Goltz, Diane, et al.
Publicado: (2016)

Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients
por: de Vos, Luka, et al.
Publicado: (2017)

PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
por: Gevensleben, Heidrun, et al.
Publicado: (2016)

Early Dynamics of Quantitative SEPT9 and SHOX2 Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis
por: Krausewitz, Philipp, et al.
Publicado: (2022)

Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract
por: Branchi, V., et al.
Publicado: (2016)

PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2017)

PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients
por: Goltz, Diane, et al.
Publicado: (2017)

DNA Methylation of PITX2 and PANCR Is Prognostic for Overall Survival in Patients with Resected Adenocarcinomas of the Biliary Tract
por: Uhl, Barbara, et al.
Publicado: (2016)

PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2016)

Correlation of SHOX2 Gene Amplification and DNA Methylation in Lung Cancer Tumors
por: Schneider, Katja U, et al.
Publicado: (2011)

PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations
por: Röver, Lea Kristin, et al.
Publicado: (2018)

Comparison between flutter valve drainage bag and underwater seal device for the management of non-massive malignant and paramalignant pleural effusions
por: Ojo, Olugbenga Olalekan, et al.
Publicado: (2020)

SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
por: Schmidt, Bernd, et al.
Publicado: (2010)

PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy
por: Holmes, Emily Eva, et al.
Publicado: (2016)

Variants in the 5′UTR reduce SHOX expression and contribute to SHOX haploinsufficiency
por: Babu, Deepak, et al.
Publicado: (2020)

Improved PCR Performance Using Template DNA from Formalin-Fixed and Paraffin-Embedded Tissues by Overcoming PCR Inhibition
por: Dietrich, Dimo, et al.
Publicado: (2013)

Expressing human SHOX in Shox2(SHOX KI)/(KI) mice leads to congenital osteoarthritis-like disease of the temporomandibular joint in postnatal mice
por: Liang, Wenna, et al.
Publicado: (2016)

Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients
por: Schmidt, Bernd, et al.
Publicado: (2015)

Profiling of conserved non-coding elements upstream of SHOX and functional characterisation of the SHOX cis-regulatory landscape
por: Verdin, Hannah, et al.
Publicado: (2015)

Role of morphometry in the cytological differentiation of benign and malignant thyroid lesions
por: Khatri, Pallavi, et al.
Publicado: (2017)

Diagnostic value of SHOX2, RASSF1A gene methylation combined with CEA level detection in malignant pleural effusion
por: Chen, Shaosen, et al.
Publicado: (2023)

Diagnostic Accuracy of Different Computed Tomography Signs for Differentiating Between Malignant and Cirrhotic Ascites Keeping Ascitic Fluid Cytology as Gold Standard
por: Zafar, Ibtesam, et al.
Publicado: (2021)

Skeletal Deformity Associated with SHOX Deficiency
por: Seki, Atsuhito, et al.
Publicado: (2014)

CYTOLOGICAL AND CYTOCHEMICAL PROPERTIES OF TEN ASCITES TUMORS
por: Love, Robert, et al.
Publicado: (1956)

Detection of SHOX2 DNA methylation by methylation-specific PCR in non-small cell lung cancer
por: Feng, Hongxiang, et al.
Publicado: (2020)

Diagnostic value of SHOX2 DNA methylation in lung cancer: a meta-analysis
por: Zhao, Qing-Tao, et al.
Publicado: (2015)

DNA Methylation Analysis of the SHOX2 and RASSF1A Panel Using Cell-Free DNA in the Diagnosis of Malignant Pleural Effusion
por: Zhang, Nana, et al.
Publicado: (2023)

Malignancy Rates of Thyroid Cytology: Cyst Fluid Benign or Non-Diagnostic?
por: Güney, Güven, et al.
Publicado: (2017)

Islet1 is a direct transcriptional target of the homeodomain transcription factor Shox2 and rescues the Shox2-mediated bradycardia
por: Hoffmann, Sandra, et al.
Publicado: (2013)

Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
por: Weiss, Gunter, et al.
Publicado: (2017)

The Diagnostic Potential of SHOX2 and RASSF1A DNA Methylation in Early Lung Adenocarcinoma
por: Gao, Hong, et al.
Publicado: (2022)

Plasma-Methylated SEPT9 for the Noninvasive Diagnosis of Gastric Cancer
por: Zhao, Luyao, et al.
Publicado: (2022)

High-grade angiosarcoma presenting with cytology-negative hemorrhagic ascites
por: Patel, Ankit P, et al.
Publicado: (2018)

Imaging-Cytology Correlation of Thyroid Nodules with Initially Benign Cytology
por: Hwang, Shin Hye, et al.
Publicado: (2014)

Rare and de novo duplications containing SHOX in clubfoot
por: Sadler, Brooke, et al.
Publicado: (2020)

shox2 is required for vestibular statoacoustic neuron development
por: Laureano, Alejandra S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2gm3p34cuf674laf05jhsie5uj